Ken Warrington

Director/Board Member at BIOSTEM TECHNOLOGIES, INC.

Net worth: 22 361 $ as of 29/06/2026

Consumer Services

Health Technology

Profile

Ken Warrington is currently Director at BioStem Technologies, Inc. since 2022, with employment at the company starting in 2019.
Former roles include Chief Technology Officer at Lacerta Therapeutics, Inc. from 2017 to 2019, Head-Strategy & Innovations at Genscript Probio Usa, Inc. from 2020 to 2021, and Senior VP-Operations & Business Development at Biostem Life Sciences, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Florida conferred in 2000 and an undergraduate degree from The St. Lawrence College conferred in 1993.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOSTEM TECHNOLOGIES, INC. 0.04%	29/09/2025	6,776 ( 0.04% )	22 361 $	29/06/2026

Ken Warrington active positions

Companies	Position	Start
BIOSTEM TECHNOLOGIES, INC.	Director/Board Member	28/02/2022

All active positions of Ken Warrington

Former positions of Ken Warrington

Companies	Position	End
GENSCRIPT PROBIO USA INC. GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017.	Corporate Officer/Principal	30/11/2021
Biostem Life Sciences, Inc.	Chief Operating Officer	30/04/2020
Lacerta Therapeutics, Inc. Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company	Chief Tech/Sci/R&D Officer	30/04/2019

See the detail of Ken Warrington's experience

Training of Ken Warrington

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ken Warrington's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
University of Florida University of Florida Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BioStem Technologies, Inc. BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies	Health Technology
The St. Lawrence College The St. Lawrence College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lacerta Therapeutics, Inc. Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company	Health Technology
GENSCRIPT PROBIO USA INC. GENSCRIPT PROBIO USA INC. Genscript Probio Usa, Inc. is a private company based in Pennington, NJ. The company was founded in 2017.
Biostem Life Sciences, Inc.